NO20013145L - Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden - Google Patents

Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden

Info

Publication number
NO20013145L
NO20013145L NO20013145A NO20013145A NO20013145L NO 20013145 L NO20013145 L NO 20013145L NO 20013145 A NO20013145 A NO 20013145A NO 20013145 A NO20013145 A NO 20013145A NO 20013145 L NO20013145 L NO 20013145L
Authority
NO
Norway
Prior art keywords
inhibitors
drug
prevention
preparation
sodium hydrogen
Prior art date
Application number
NO20013145A
Other languages
English (en)
Other versions
NO20013145D0 (no
Inventor
Wolfgang Linz
Hans Jochen Lang
Bela Kelety
Peter Schmid
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20013145D0 publication Critical patent/NO20013145D0/no
Publication of NO20013145L publication Critical patent/NO20013145L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20013145A 1998-12-23 2001-06-22 Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden NO20013145L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859727A DE19859727A1 (de) 1998-12-23 1998-12-23 Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
PCT/EP1999/009621 WO2000038661A2 (de) 1998-12-23 1999-12-08 Die verwendung von hemmern des natrium-wasserstoff-austauschers zur herstellung eines medikaments zur verhinderung von altersbedingten organ-dysfunktionen, altersbedingten erkrankungen und zur lebensverlängerung

Publications (2)

Publication Number Publication Date
NO20013145D0 NO20013145D0 (no) 2001-06-22
NO20013145L true NO20013145L (no) 2001-08-22

Family

ID=7892436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013145A NO20013145L (no) 1998-12-23 2001-06-22 Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden

Country Status (20)

Country Link
US (1) US6420430B1 (no)
EP (1) EP1140056A2 (no)
JP (1) JP2002533386A (no)
KR (1) KR20010086152A (no)
CN (1) CN1367689A (no)
AR (1) AR021965A1 (no)
AU (1) AU776761B2 (no)
BR (1) BR9916505A (no)
CA (1) CA2357837A1 (no)
CZ (1) CZ20012309A3 (no)
DE (1) DE19859727A1 (no)
HR (1) HRPK20010470B1 (no)
HU (1) HUP0104652A3 (no)
IL (1) IL143372A0 (no)
NO (1) NO20013145L (no)
RU (1) RU2238721C2 (no)
SK (1) SK9042001A3 (no)
TR (1) TR200101803T2 (no)
WO (1) WO2000038661A2 (no)
ZA (1) ZA200104301B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2004126702A (ru) * 2002-02-04 2005-04-20 АВЕНТИС ФАРМА ДОЙЧЛАНД ГмбХ (DE) Комбинированный препарат на основе ингибитора натрий-водородного обмена карипорида с ингибиторами ангиотензинконвертирующего фермента для предотвращения сердечной недостаточности и других, обусловленных возрастом дисфункций органов, обусловленных возрастом заболеваний и для продления жизни
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US7375138B2 (en) * 2002-05-18 2008-05-20 Sanofi-Aventis Deutschland Gmbh Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
US6878748B2 (en) 2002-06-13 2005-04-12 Aventis Pharma Deutschland Gmbh Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them
EP2617709B8 (en) * 2003-06-26 2022-12-21 Biotron Limited Guanidine derivatives as antiviral agents
US7947897B2 (en) * 2005-11-02 2011-05-24 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8013240B2 (en) * 2005-11-02 2011-09-06 The Trustees Of Princeton University Organic photovoltaic cells utilizing ultrathin sensitizing layer
US8017863B2 (en) * 2005-11-02 2011-09-13 The Regents Of The University Of Michigan Polymer wrapped carbon nanotube near-infrared photoactive devices
KR101042078B1 (ko) * 2009-01-13 2011-06-16 한국항공우주산업 주식회사 치공구 제작용 수평 측면 가공 치구
CN104103253B (zh) 2014-07-04 2016-08-17 京东方科技集团股份有限公司 发射电极扫描电路、阵列基板和显示装置

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE59305042D1 (de) 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
PT590455E (pt) * 1992-09-28 2001-04-30 Hoechst Ag 1(2h)-isoquinolinas substituidas anti-arritmicas e cardioprotectoras processo para a sua preparacao medicamento contendo estes compostos e sua utilizacao para a preparacao de um medicamento para o combate de falhas cardiacas
SE508028C2 (sv) * 1993-05-12 1998-08-10 Moelnlycke Ab Midjebälte för absorberande plagg
DE4328352A1 (de) 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4404183A1 (de) * 1994-02-10 1995-08-17 Merck Patent Gmbh 4-Amino-1-piperidylbenzoylguanidine
EP0669666B1 (en) 1994-02-25 1997-12-17 WHITEHEAD ALENIA SISTEMI SUBACQUEI S.p.A. Electrolyte-activated battery
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
DE19502644A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh 4-Amino-benzoylguanidin-Derivate
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DK0738712T3 (da) * 1995-04-18 2000-03-06 Hoechst Ag Substituerede indenoylguanidiner med antiarytmetisk kardioprotektiv virkning
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19621319A1 (de) * 1996-05-28 1997-12-04 Hoechst Ag Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19622222A1 (de) * 1996-06-03 1997-12-04 Hoechst Ag Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide
JP2002502414A (ja) * 1997-06-02 2002-01-22 藤沢薬品工業株式会社 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体
DE19734693A1 (de) * 1997-08-11 1998-01-22 Hoechst Marion Roussel De Gmbh Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
CA2260499A1 (en) * 1998-01-29 1999-07-29 Sumitomo Pharmaceuticals Company Limited Pharmaceutical compositions for the treatment of ischemic brain damage

Also Published As

Publication number Publication date
WO2000038661A2 (de) 2000-07-06
CA2357837A1 (en) 2000-07-06
RU2238721C2 (ru) 2004-10-27
HRP20010470A2 (en) 2002-06-30
AU1657600A (en) 2000-07-31
EP1140056A2 (de) 2001-10-10
DE19859727A1 (de) 2000-06-29
CZ20012309A3 (cs) 2001-09-12
AR021965A1 (es) 2002-09-04
IL143372A0 (en) 2002-04-21
BR9916505A (pt) 2001-11-20
CN1367689A (zh) 2002-09-04
KR20010086152A (ko) 2001-09-08
TR200101803T2 (tr) 2001-10-22
NO20013145D0 (no) 2001-06-22
SK9042001A3 (en) 2001-12-03
HUP0104652A3 (en) 2002-09-30
AU776761B2 (en) 2004-09-23
WO2000038661A3 (de) 2000-11-09
ZA200104301B (en) 2003-02-20
RU2001120358A (ru) 2005-12-10
HRPK20010470B1 (en) 2003-10-31
HUP0104652A2 (hu) 2002-03-28
US6420430B1 (en) 2002-07-16
JP2002533386A (ja) 2002-10-08

Similar Documents

Publication Publication Date Title
IL145907A0 (en) Use of glucosylceramide synthesis inhibitors in therapy
GB0013378D0 (en) Use of therapeutic benzamide derivatives
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
NO20013145L (no) Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden
DE69429202D1 (de) Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes
NO983926L (no) Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
PL345776A1 (en) Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
SE9700934D0 (sv) New formulation
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
ITMI20001051A0 (it) Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari
ATE306267T1 (de) Kombinationsbehandlung bei akutem myokardinfarkt
HK1046089A1 (zh) 褪黑激素的治疗用途
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
BR0308795A (pt) Amidas do ácido sulfamico
ITRM990719A0 (it) Uso di ubichinone q10 per il trattamento locale e la prevenzione di patalogie aftalmologiche secondarie alla terapia fotorefrattiva, chirurg
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
NO20003799D0 (no) Innkorporering av kolesterol-senkende midler i konfektdosisformer
NO20006349D0 (no) Hydroksamsyrederivater som inhibitorer for produksjon av humant CD23 og av TNF-frigjöring
AU2001282551A1 (en) Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases
TW200509945A (en) Agent for treatment of anal disease
EE200200227A (et) Tüüp 1 naatrium-vesinik ioniidi inhibiitori kristallid
AU2001240885A1 (en) Use of glucosylceramide synthesis inhibitors in brain cancer therapy
CA2304899A1 (en) New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease
ID26666A (id) Penggunaan agen untuk pencegahan penyakit gusi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application